_2020091018165303jzv.jpg "Decoding The World Of ETF")
- Moneycontrol /
- Market /
- Pharmaceuticals /
- CASH FLOW
BSE Live
Oct 20, 16:00Prev. Close
5051.45
Open Price
5100.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 20, 15:59Prev. Close
5058.15
Open Price
5056.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5071.15 (121)
| Cash Flow of Dr Reddys Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2,775.80 | 1,700.70 | 697.00 | 1,544.50 | 1,580.00 | |
| Net CashFlow From Operating Activities | 1,839.20 | 2,762.10 | 1,538.60 | 1,015.90 | 2,798.20 | |
| Net Cash Used In Investing Activities | -1,689.20 | -550.90 | -1,179.90 | 1,442.50 | -1,961.10 | |
| Net Cash Used From Financing Activities | -224.10 | -2,223.10 | -304.40 | -2,581.80 | -693.70 | |
| Foreign Exchange Gains / Losses | 0.00 | 4.40 | -0.30 | -12.00 | -9.20 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -74.10 | -7.50 | 54.00 | -135.40 | 134.20 | |
| Cash And Cash Equivalents Begin of Year | 113.20 | 120.70 | 66.70 | 202.10 | 60.00 | |
| Cash And Cash Equivalents End Of Year | 39.10 | 113.20 | 120.70 | 66.70 | 194.20 |
17.10.2020
06.10.2020
Accumulate Dr. Reddy's Laboratories; target of Rs 5648: Prabhudas Lilladher
06.10.2020
24.09.2020
Accumulate Dr. Reddy's Laboratories; target of Rs 5648: Prabhudas Lilladher
29.07.2020
Dr Reddy's Labs Q1 Preview: Profit may decline on higher base, but revenue can grow over 5%
14.10.2019
12.07.2019
Dr. Reddy’s Laboratories Q1 PAT seen up 13.6% YoY to Rs. 540.8 cr: Prabhudas Lilladher
17.05.2019
Dr Reddy's Q4 preview: Profit to rise 37% YoY to Rs 413cr; EBITDA margin may touch 23%
